A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Conditions
DLBCL · Diffuse Large B-Cell Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175), Glendale, Arizona, United States
Beverly Hills Cancer Center ( Site 0184), Beverly Hills, California, United States
Bass Medical Group ( Site 0166), Walnut Creek, California, United States
Innovative Clinical Research Institute ( Site 0122), Whittier, California, United States
Boca Raton Regional Hospital- Lynn Cancer Institute ( Site 0163), Boca Raton, Florida, United States
Clermont Oncology Center ( Site 0174), Clermont, Florida, United States
BRP-Hialeah Hospital ( Site 0182), Hialeah, Florida, United States
Illinois Cancer Specialists ( Site 8000), Niles, Illinois, United States
Saint Elizabeth Medical Center Edgewood ( Site 0165), Edgewood, Kentucky, United States
University of Kentucky Chandler Medical Center ( Site 0158), Lexington, Kentucky, United States
Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0133), Louisville, Kentucky, United States
University of Maryland ( Site 0123), Baltimore, Maryland, United States
Dana-Farber Cancer Institute-Lymphoma ( Site 0111), Boston, Massachusetts, United States
University of Massachusetts Medical School ( Site 0119), Worcester, Massachusetts, United States
Corewell Health ( Site 0162), Grand Rapids, Michigan, United States
St. Vincent Frontier Cancer Center-Research ( Site 0108), Billings, Montana, United States
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188), Grand Island, Nebraska, United States
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0177), Omaha, Nebraska, United States
Comprehensive Cancer Centers of Nevada ( Site 0168), Las Vegas, Nevada, United States
Atlantic Health System ( Site 0116), Morristown, New Jersey, United States
Presbyterian Rust Jorgensen Cancer ( Site 9506), Rio Rancho, New Mexico, United States
New York Medical College ( Site 0113), Valhalla, New York, United States
Alliance Cancer Specialists (ACS) ( Site 8001), Horsham, Pennsylvania, United States
Tennessee Cancer Specialists ( Site 7000), Knoxville, Tennessee, United States
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0156), Nashville, Tennessee, United States
Blue Ridge Cancer Care ( Site 0169), Roanoke, Virginia, United States
Hospital Italiano de Buenos Aires ( Site 2203), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Instituto de Investigaciones Clínicas Mar del Plata ( Site 2205), Mar del Plata, Buenos Aires, Argentina
Hospital Aleman ( Site 2200), Buenos Aites, Buenos Aires F.D., Argentina
Hospital Privado Universitario de Córdoba ( Site 2202), Córdoba, Córdoba Province, Argentina
Instituto Alexander Fleming ( Site 2201), CABA, Argentina
Townsville University Hospital ( Site 1800), Douglas, Queensland, Australia
Grampians Health ( Site 1802), Ballarat, Victoria, Australia
Royal Perth Hospital-Haematology ( Site 1801), Perth, Western Australia, Australia
Hospital Erasto Gaertner ( Site 2302), Curitiba, Paraná, Brazil
Liga Norte Riograndense Contra o Câncer ( Site 2305), Natal, Rio Grande do Norte, Brazil
Hospital Paulistano ( Site 2300), São Paulo, Brazil
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0200), Toronto, Ontario, Canada
Biocenter ( Site 2401), Concepción, Biobio, Chile
IC La Serena Research ( Site 2405), La Serena, Coquimbo Region, Chile
Oncocentro Valdivia ( Site 2407), Valdivia, Los Ríos Region, Chile
FALP-UIDO ( Site 2400), Santiago, Region M. de Santiago, Chile
Clínica Inmunocel ( Site 2404), Santiago, Region M. de Santiago, Chile
Clínica RedSalud Vitacura ( Site 2409), Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 2403), Santiago, Region M. de Santiago, Chile
Beijing Cancer hospital ( Site 3000), Beijing, Beijing Municipality, China
Chongqing University Cancer Hospital-Medical Oncology ( Site 3025), Chongqing, Chongqing Municipality, China
Chongqing University Three Gorges Hospital ( Site 3026), Chongqing, Chongqing Municipality, China
Sun Yat-sen University Cancer Center-Internal Medicine ( Site 3001), Guangzhou, Guangdong, China
Zhujiang Hospital ( Site 3002), Guangzhou, Guangdong, China
The First Affiliated Hospital of Henan University of Science &Technology ( Site 3029), Luoyang, Henan, China
Henan Cancer Hospital-hematology department ( Site 3013), Zhengzhou, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 3017), Wuhan, Hubei, China
The First Affiliated Hospital of Nanchang University ( Site 3004), Nanchang, Jiangxi, China
Jiangxi Provincial Cancer Hospital ( Site 3005), Nanchang, Jiangxi, China
The First Hospital of Jilin University-Hematology ( Site 3012), Changchun, Jilin, China
Fudan University Shanghai Cancer Center ( Site 3009), Shanghai, Shanghai Municipality, China
Sichuan Cancer hospital-Oncology ( Site 3021), Chengdu, Sichuan, China
West China Hospital of Sichuan University-Head and Neck Oncology ( Site 3016), Chengdu, Sichuan, China
Zhejiang Cancer Hospital ( Site 3014), Hangzhou, Zhejiang, China
The First Affiliated Hospital Zhejiang University School of Medicine ( Site 3027), Hangzhou, Zhejiang, China
Hospital Pablo Tobon Uribe ( Site 0804), Medellín, Antioquia, Colombia
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0801), Bogotá, Bogota D.C., Colombia
Instituto Médico de Alta Tecnologia S.A.S ( Site 0803), Montería, Departamento de Córdoba, Colombia
Oncologos del Occidente ( Site 0800), Pereira, Risaralda Department, Colombia
Fundacion Valle del Lili ( Site 0802), Cali, Valle del Cauca Department, Colombia
Hospital Metropolitano - Sede Lindora ( Site 2500), Santa Ana, Provincia de San José, Costa Rica
CIMCA ( Site 2501), San José, Costa Rica
Aarhus Universitetshospital, Skejby ( Site 1701), Aarhus, Central Jutland, Denmark
centre hospitalier lyon sud-Service Hématologie ( Site 0702), Pierre-Bénite, Rhone, France
Pitie Salpetriere University Hospital-Clinical haematology ( Site 0700), Paris, France
Evangelismos General Hospital of Athens ( Site 0900), Athens, Attica, Greece
Regional General Hospital of Athens "Laiko" ( Site 0901), Athens, Attica, Greece
University Hospital of Alexandroupolis ( Site 0903), Alexandroupoli, East Macedonia and Thrace, Greece
MEDI-K ( Site 2602), Guatemala City, Guatemala
Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 2601), Guatemala City, Guatemala
CELAN,S.A ( Site 2603), Guatemala City, Guatemala
Queen Mary Hospital ( Site 3100), Hong Kong, Hong Kong
Princess Margaret Hospital ( Site 3101), Hong Kong, Hong Kong
Emek Medical Center-Hematology Unit ( Site 1102), Afula, Israel
Carmel Hospital ( Site 1103), Haifa, Israel
Hadassah Medical Center ( Site 1100), Jerusalem, Israel
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1203), Rozzano, Milano, Italy
IRCCS - AOU di Bologna-Istituto di Ematologia "L. e A. Seragnoli" ( Site 1200), Bologna, Italy
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1202), Naples, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -ISTITUTO DI EMATOLOGIA ( Site 1204), Roma, Italy
Hokkaido University Hospital ( Site 3202), Sapporo, Hokkaido, Japan
Tokai University Hospital ( Site 3212), Isehara, Kanagawa, Japan
Mie University Hospital ( Site 3210), Tsu, Mie-ken, Japan
Kansai Medical University Hospital ( Site 3203), Hirakata, Osaka, Japan
Tokyo Metropolitan Komagome Hospital ( Site 3200), Bunkyo, Tokyo, Japan
The Jikei University Hospital ( Site 3208), Minato, Tokyo, Japan
University of Yamanashi Hospital ( Site 3201), Chūō, Yamanashi, Japan
National Hospital Organization Kyushu Cancer Center ( Site 3204), Fukuoka, Japan
Fukushima Medical University Hospital ( Site 3207), Fukushima, Japan
University Hospital,Kyoto Prefectural University of Medicine ( Site 3209), Kyoto, Japan
University of Miyazaki Hospital ( Site 3211), Miyazaki, Japan
Osaka Metropolitan University Hospital ( Site 3205), Osaka, Japan
Yamagata University Hospital ( Site 3206), Yamagata, Japan
Health Pharma Professional Research S.A. de C.V: ( Site 2700), Mexico City, Mexico City, Mexico
Medivest Centro de Investigación Integral ( Site 2704), Chihuahua City, Mexico
Centro de Infusion Superare ( Site 2701), Mexico City, Mexico
Aotearoa Clinical Trials ( Site 0501), Auckland, New Zealand
Clínicas AUNA Sede Chiclayo ( Site 2803), Chiclayo, Lambayeque, Peru
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 2800), Surquillo, Muni Metro de Lima, Peru
Clínica San Felipe ( Site 2805), Lima, Peru
Hospital Nacional Edgardo Rebagliati Martins ( Site 2802), Lima, Peru
Hospital Nacional Dos De Mayo ( Site 2804), Lima, Peru
Pratia MCM Krakow ( Site 1303), Krakow, Lesser Poland Voivodeship, Poland
Specjalistyczny Szpital im. Dr Alfreda Sokolowskiego w Walbrzychu ( Site 1305), Wałbrzych, Lower Silesian Voivodeship, Poland
Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site 1301), Wroclaw, Lower Silesian Voivodeship, Poland
Centrum Onkologii Ziemi Lubelskiej-Oddzial Hematologii i Transplantacji Szpiku ( Site 1304), Lublin, Lublin Voivodeship, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( Site 1300), Warsaw, Masovian Voivodeship, Poland
Szpitale Pomorskie Sp. z o. o.-Hematology and Bone Marrow Transplantation Department ( Site 1302), Gdynia, Pomeranian Voivodeship, Poland
Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku ( Site 1309), Słupsk, Pomeranian Voivodeship, Poland
Pratia Onkologia Katowice ( Site 1306), Katowice, Silesian Voivodeship, Poland
Seoul National University Hospital-Oncology ( Site 0302), Seoul, South Korea
Samsung Medical Center ( Site 0300), Seoul, South Korea
Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 0400), Bangkok, Bangkok, Thailand
Chulalongkorn University ( Site 0402), Pathumwan, Bangkok, Thailand
Maharaj Nakorn Chiang Mai Hospital ( Site 0401), Chiang Mai, Thailand
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi ( Site 1912), Yenimahalle, Ankara, Turkey (Türkiye)
Ege University Medicine of Faculty ( Site 1902), Bornova, İzmir, Turkey (Türkiye)
Ankara University Hospital Cebeci-hematology ( Site 1901), Ankara, Turkey (Türkiye)
Mega Medipol-Hematology ( Site 1909), Istanbul, Turkey (Türkiye)
Dokuz Eylül Üniversitesi-Hematology ( Site 1905), Izmir, Turkey (Türkiye)
Ondokuz Mayıs Universitesi ( Site 1907), Samsun, Turkey (Türkiye)
MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2000), Cherkasy, Cherkasy Oblast, Ukraine
Communal non-profit enterprise "Regional clinical hospital of Ivano-Frankivsk Regional Council" ( Site 2004), Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
Institute of Blood Pathology and Transfusion Medicine AMS Ukraine ( Site 2002), Lviv, Lviv Oblast, Ukraine
State non-profit enterprise National Cancer Institute ( Site 2001), Kyiv, Ukraine
National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine ( Site 2005), Kyiv, Ukraine
Aberdeen Royal Infirmary ( Site 2104), Aberdeen, Aberdeen City, United Kingdom
The Royal Cornwall Hospital ( Site 2103), Truro, England, United Kingdom
University College London Hospital-Cancer Clinical Trials Unit ( Site 2100), London-Camden, London, City of, United Kingdom
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC